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High-redox potential laccases are powerful bio-
catalysts with a wide range of applications in
biotechnology. We have converted a thermostable
laccase from a white-rot fungus into a blood tolerant
laccase. Adapting the fitness of this laccase to the
specific composition of human blood (above neutral
pH, high chloride concentration) required several
generations of directed evolution in a surrogate
complex blood medium. Our evolved laccase was
tested in both human plasma and blood, displaying
catalytic activity while retaining a high redox poten-
tial at the T1 copper site. Mutations introduced
in the second coordination sphere of the T1 site
shifted the pH activity profile and drastically reduced
the inhibitory effect of chloride. This proof of concept
that laccases can be adapted to function in extreme
conditions opens an array of opportunities for
implantable nanobiodevices, chemical syntheses,
and detoxification.
INTRODUCTION
The extension of an enzymes’ capacity to function in extreme
environmental conditions is an issue that promises to deliver
countless benefits. Due to their extraordinary versatility, the
study of the ligninolytic enzymatic consortium of oxidoreduc-
tases secreted by white-rot fungi is of special biotechnological
interest—mainly high-redox potential laccases (HRPLs), peroxi-
dases, and H2O2-supplying enzymes (Martı´nez et al., 2009).
However, the absence of catalytic activity at neutral/basic pHs,
along with the inhibition by modest concentrations of different
substances (halides, metal ions, fatty acids, detergents), remain
a serious obstacle to their further exploitation. HRPLs (EC
1.10.3.2) that are active under such inclement conditions would
be very desirable to be used in applications that range from
organic synthesis to bioremediation (Alcalde, 2007; Gianfreda
et al., 1999). In addition, HRPLs belong to the exclusive group
of oxidoreductases that are capable of accepting electrons
directly from the cathode of a biofuel cell or an amperometric
biosensor. Indeed, the set of advantages that HRPLs have to
offer (i.e., high current densities, direct electron transfer, lowChemistry & Biology 20, 223overpotential for O2 reduction, and high operational stability)
situate them among the best suited candidates for enzyme-
based bioelectronic devices (Shleev and Ruzgas, 2008).
Possibly, one of the most attractive challenges in this field
focuses on achieving implantable self-contained wireless 3D-
nanobiodevices that work in different physiological fluids (blood,
saliva, tears). Such nanobioelectronic devices are comprised
of a biosensor array to detect different metabolites in vivo
(glucose, insulin), a transmitter/transducer to externalize the
information and a biofuel cell to power the entire system. The
main shortcomings in the engineering of this type of technology
stem from the difficulties in miniaturizing their individual
elements (antenna, transducer), and in tailoring reliable and
stable enzymes to catalyze the biocathode reaction in which
the O2 dissolved in the fluids is reduced to H2O (Bullen et al.,
2006; Castillo et al., 2004; Kim et al., 2006). Unfortunately,
HRPLs are inactive at blood pH (7.4) and they are also strongly
inhibited by chloride concentrations much lower than those
found in blood (140–150 mM), which limits this specific applica-
tion and the use in other areas where basic pHs or chloride ions
are presented (i.e., dye-stuff processing, waste-water treatment,
pollutant remediation, pharmaceutical compound synthesis,
and food processing, to name a few) (Alcalde, 2007; Gianfreda
et al., 1999; Riva, 2006; Rodgers et al., 2010).
Here, we report the engineering by directed evolution of an
HRPL that is functional in human blood. The ultimate mutant
enzyme obtained through this evolutionary process was charac-
terized comprehensively and its evolved features were tested
on real human blood samples, revealing the mechanisms
underlying this relevant improvement.
RESULTS AND DISCUSSION
Laboratory Evolution Approach
Our point of departure in this study was a HRPL (OB-1 mutant)
previously tailored in our laboratory by in vitro evolution and
semirational approaches to be active, soluble, highly thermo-
stable, and readily secreted by yeast (Mate´ et al., 2010). To
convert OB-1 to an active blood-tolerant laccase, we designed
a screening assay based on human blood composition. As real
plasma or blood are unsuitable for screening mutant libraries in
the experimental context of directed evolution, we developed
a surrogate complex medium (‘‘blood-buffer’’) mimicking the
biochemical composition of human blood. This buffer contained
a laccase colorimetric substrate but it lacked any cells and coag-
ulating agents. Three consecutive rescreens were conducted to–231, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 223
Figure 1. Directed Laccase Evolution
The parental type fusion gene (OB-1 mutant) (Mate´ et al., 2010) is formed by the a-factor prepro-leader, replacing the original laccase signal sequence to improve
secretion in S. cerevisiae, and the mature laccase. The a-factor preleader is represented in orange, the a-factor proleader in blue and the mature laccase in red.
(legend continued on next page)
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mutant exhibits neither activity nor significant internal electron
transfer at pH 7.4 (Mate´ et al., 2010). Accordingly, for the first
generation the pH of the blood-buffer was set at 6.5, resulting
in a decrease in laccase activity of over 90%. In successive
generations selective pressure was progressively enhanced
until physiological pH values were reached. We took advantage
of the high frequency of homologous DNA recombination of
the Saccharomyces cerevisiae machinery to create diversity
(Alcalde, 2010; Gonzalez-Perez et al., 2012). Thus, in each evolu-
tion cycle different DNA-recombination methods (both in vivo
and in vitro) were combined to enhance the complexity of the
mutant libraries in this pool. The last round of evolution was
dedicated to the detailed rational evaluation of several positions
that produced substantial improvements in the total activity by
saturation mutagenesis, site-directed mutagenesis, and muta-
tional recovery (Figure 1; Table S1 and Supplemental Results
available online). When the last variant of the evolutionary
pathway was obtained (ChU-B mutant), it exhibited an increase
in total activity in blood-buffer over 40,000-fold versus the
parental type.
Laccase Mutant in Blood
The behavior of the mutant laccase was tested in human plasma
and blood. Oxygen consumption in physiological fluids enriched
with ascorbic acid (a poor laccase substrate naturally present
in blood) was monitored with a Clark electrode, revealing com-
parable responses for plasma and blood (185 and 127 min1,
respectively; Figure 2A). The 1.5-fold increase in ChU-B activity
in plasma suggested that blood cells interfere with the detec-
tion method. To confirm that the enzyme was active under
physiological conditions regardless of the reducing substrate
used, oxygen reduction against common laccase substrates
(2,20-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS),
K4[Fe(CN)6]) was measured in blood-buffer, obtaining similar
values for all compounds tested (Figure 2A).
Laccases contain four catalytic copper (Cu) ions arranged at
two different sites: the T1 site, at which the substrate is oxidized,
and a trinuclear Cu cluster (with one Cu T2 and two Cu T3), at
which oxygen is reduced to water (Morozova et al., 2007). If the
laccase is properly connected to an electrode via the T1 Cu,
the electroactive surface of the device can replace the elec-
tron-donating natural substrates of the enzyme. Redox titration
of the T1 Cu site was performed at physiological pH using a
microspectroelectrochemical cell with a gold capillary electrode
(Figure 2B). The ChU-B mutant exhibited a high redox potential
(+720mVversusNHE) at pH 7.4, and it reversibly cycled between
its fully oxidized and fully reduced state. To further verify that the
mutant was electrochemically active under physiological condi-
tions,ChU-Bwas adsorbedonto low-density graphite electrodesNewmutations are depicted as stars and accumulated mutations as squares; A38
indicating the improvement in laccase activity detected in S. cerevisiae microcul
performed in quintuplicate from supernatants of independent cultures grown in 96
indicates the concentration of NaCl at which the enzyme retains 50%of its ABTS-a
incubation. Relative activity at different pH values was assessed with 3 mM ABT
generation. N.d., not determined. Silent mutations are not included. Over 10,000
(IvAM, DNA shuffling, IVOE) and in vitro (error-prone PCR, mutagenic StEP) reco
(ChU-B) was obtained after analyzing several positions by site-directed mutagen
See also Supplemental Results, Tables S1 and S5, and Figure S3.
Chemistry & Biology 20, 223and the electrocatalytic response of O2 reduction by direct elec-
tron transfer was recorded at pH 7.4 (Figure 2C). No responses
were detected for any of the HRPLs tested at this pH.
Inhibition by Halides and Hydroxides
The novel properties of ChU-B were dissected in terms of its
activity versus pH and halide inhibition. The pH activity profiles
against phenolic (2,6-dimethoxyphenol) (DMP) and nonphenolic
(ABTS) compounds revealed a notable shift toward less acidic
values, including a change in DMP optimum activity pH from
4.0 to 5.0–6.0 (Figures 3A, 3B, S1A, and S1B). At pH 7.0, ChU-
B retained 50% and 20% of its activity for DMP and ABTS,
respectively, whereas the parental type displayed negligible
activity under these conditions. Similarly, ChU-B activity at
pH 6.0 was over 90% and 50% for DMP and ABTS, respectively,
whereas that of the parental type was 20%. This drastic
improvement in activity at near neutral pH led to a small but
noticeable increase in ChU-B activity even at pH 8.0. To date,
the engineering of chimeric laccases had only succeeded in
slightly shifting the pH profile, at the expense of sacrificing redox
potential (Cusano et al., 2009). By contrast, ChU-B variant
exhibits activity at neutral/alkaline pH values while keeping
a high redox potential at the T1 Cu site.
It is well known that increases in pH inhibit laccase activity,
due to a decrease in H+ availability and the binding of OH
ions to the T2 Cu, which in our laccase is tricoordinated with
His64, His397, and one H2O molecule (Matera et al., 2008; Xu,
1997). HRPLs are also inhibited by halides (fluoride, chloride,
and bromide, but not iodide), with an inhibitory potency inversely
proportional to the diameter of the anion (F > Cl > Br). This
dependence is possibly due to an access limitation for the
binding of the larger halide ions to the laccase catalytic sites
(Xu, 1996, 1997). The I50 measured for the different halides (the
concentration of halide at which the enzyme retains 50% of
its initial activity) was independent of the substrate employed
(Table S2). The I50 of ChU-B for Cl
 improved from 176 to
1,025 mM with ABTS as substrate (Figure 3C), to the best of
our knowledge the highest I50Cl reported for any basidiomycete
HRPL. It was not possible to measure Br inhibition for Chu-B,
as the I50 of the parental type was already above 1,300 mM,
impeding measurement by surpassing the limit of substrate
solubility at such high salt-concentrations. As expected, there
was strong inhibition in the presence of F (in the mM range),
and although F inhibition was not a goal of the directed
evolution study, the I50F was slightly enhanced (from 70 to
109 mM, Figure 3D). Halide inhibition was alsomeasured at phys-
iological pH values and ChU-B was not sensitive to increasing
concentrations of chloride (ranging from 100 to 800 mM) (Fig-
ure 3E). At pH 7.4, very little H2O dissociation was observed,
although the resulting 251 nM of OH may be enough to9- is a deleted residue. TAI (total activity improvement in blood-buffer): a value
tures for each mutant compared with the parental OB-1. Measurements were
-well plates, using 3 mMABTS as substrate. The apI50Cl (apparent I50 for NaCl)
ctivity, as determined in S. cerevisiaemicrocultures for eachmutant after a 2 hr
S as substrate. Dashed arrows indicate the mutant used as a parent in each
clones were screened in four rounds of molecular evolution combining in vivo
mbination/mutagenic methods. In the last cycle of evolution, the final variant
esis and saturation mutagenesis.
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Figure 2. Activity in Physiological Fluids and Spectro-Electrochem-
ical Characterization
(A) Activity of the ChU-Bmutant determined bymeasuring O2 consumption. To
monitor laccase activity in blood and plasma, the fluids were supplemented
with 10 mM ascorbic acid and the pH adjusted to 7.4 prior to adding the
enzyme. Each bar, including the SD, is from three independent experiments.
(B) Redox titration of ChU-B at physiological pH values. Each redox titration
was carried out in both directions: from the fully oxidized to the fully reduced
state of the enzyme (reductive titration) and vice versa (oxidative titration). The
spectra of laccases were recorded at redox equilibrium and typical spectra
of the oxidized, partly reduced and fully reduced enzymes are depicted.
Equilibration of the T1 copper center at each potential applied was apparent
from the stabilization of absorbance at 600 nm. As the redox mediators used
are transparent above 500 nm, the spectral changes at 600 nmwere attributed
to the T1 Cu of the laccase. Spectra from the reductive titration, corresponding
to oxidized laccase (black curve, applied potential +1,000 mV versus NHE),
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226 Chemistry & Biology 20, 223–231, February 21, 2013 ª2013 Elseefficiently bind at the T2 Cu site and promote the inhibition of
native HRPLs. The gradual increase in blood-buffer pH
throughout evolution reflects the [OH] increase and [H+]
decrease, and it permitted a selection of variants that are more
tolerant to both hydroxyl and chloride ions in the same screening
assay. Comparing ChU-B with other HRPLs revealed that, de-
pending on the substrate, our variant was 12- to 20-fold less
sensitive to F than the HRPLs from Trametes trogii and Tra-
metes villosa (Garzillo et al., 1998; Xu, 1996). Similarly, the
I50Cl of ChU-B was 26- to 164-fold higher than corresponding
HRPLs. The ascomycete laccase from Botrytis aclada exhibited
the highest I50Cl described to date (1.4 M with DMP as
substrate) (Kittl et al., 2012), yet its negligible activity at neutral
pH and poor stability precludes its use in implantable bio-
cathodes or other environmental processes. Comparing ChU-
B with laccases from bacterial sources revealed a 1.5-fold better
chloride tolerance than that of the halide-resistant polyphenol
oxidase from Marinomonas mediterranea (Jimenez-Juarez
et al., 2005). This halide tolerance of the Chu-Bmutant is remark-
able given that, as a rule, fungal laccases are much more sensi-
tive to halide inhibition than low-redox potential laccases from
bacteria (Niladevi et al., 2008; Singh et al., 2011).
We assessed maximum turnover rates of ChU-B in blood-
buffer. The synergic effect that improved activity at physiological
pH in association with a strong chloride tolerance resulted in
initial rates of 427 and 143 mol substrate/min/mol enzyme for
DMP and ABTS, respectively. In equivalent conditions, the
parental type showed almost no activity. Significantly, the turn-
over rates of the ChU-B mutant was 3- to 4-fold lower than
that of the parental type under optimal conditions (i.e., acidic
pH and in the absence of inhibitors; Table S3). Intrigued by these
results, we analyzed mutations in the laccase structure.
Structural Analysis of Mutations
The laccase catalytic scaffold is formed by the T1 Cu site
close to the surface, although the copper is not solvent-
exposed. The T1 Cu is trigonally coordinated by His455,
His394, and Cys450, the latter forming part of the highly-
conserved His451-Cys450-His449 tripeptide, which connects
to the trinuclear cluster located 12 A˚ away. The electrons
from T1 Cu are transferred through two intramolecular electron
transfer pathways governed by the aforementioned tripeptide
to the T2/T3 trinuclear Cu cluster, where O2 binds and is
reduced to two molecules of H2O. This second active site is
buried deep in the laccase structure, with a T2 Cupartly reduced enzymes (red and blue curves, +700 mV and +600 mV versus
NHE, respectively) and the fully reduced laccase (green curve, +300mV versus
NHE) are shown. Inset: a typical Nernst plot of the dependence of the applied
potential versus absorbance at 600 nm, and averaged parameters calculated
from the reductive and oxidative titrations (midpoint value of +720 mV versus
NHE and a slope of 110 mV).
(C) Cyclic voltammograms of O2 reduction obtained using a polished, low-
density graphite (LDG) electrode (black), and a LDG electrode with ChU-B
laccase adsorbed to its surface (red). Measurements were carried out in
a three-electrode electrochemical cell filled with 100 mM sodium phosphate
buffer pH 7.4 and after bubbling O2 at a pressure of 1 atm for 15 min, using
a platinum wire as the counter electrode and a BAS Ag/AgCl reference elec-
trode. Measurements were performed using Autolab PGSTAT30 controlled by
GPES 4.9 software.
vier Ltd All rights reserved
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Figure 3. Biochemical Characterization
(A and B) pH activities profiles were measured in 100 mM Britton and Robinson buffer at different pH values with 3 mMDMP (A) or ABTS (B) as substrates. White
circles, parental type; black circles, ChU-B mutant. Laccase activity was normalized to the optimum activity value.
(C–E) Inhibition by halides. (C) Cl inhibition measured with 2.4 mM ABTS in 100 mM sodium acetate buffer pH 4.0. (D) F inhibition measured with 2.4 mM ABTS
in 100 mM sodium acetate buffer pH 4.0. (E) Cl inhibition of ChU-B measured with 2.4 mM ABTS in 100 mM sodium phosphate buffer pH 7.4. Each value
represents the mean and SD derived from three independent experiments.
See also Figure S1 and Tables S2 and S3.
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two tetracoordinated T3 coppers. The entrance of O2 and the
exit of H2O to the T2/T3 site occur via two solvent channels.
Bearing in mind that halide/OH inhibition allegedly occurs at
the T2/T3 cluster, interrupting the internal electron transfer
(Naki and Varfolomeev, 1981; Naqui and Varfolomeev, 1980),
we expected to find mutations located in the surroundings ofChemistry & Biology 20, 223the trinuclear copper cluster, or in either of the two channels
for oxygen and water transit (Matera et al., 2008; Xu et al.,
1998). However, the two mutations introduced in the mature
ChU-B (F396I and F454E) were located at the second coordi-
nation sphere of the T1 Cu site (Figure 4). Indeed, most of
the mutations discovered during the course of evolution were
placed in the same region (at an average distance of 7.5 A˚–231, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 227
AB
Figure 4. Mutations in Evolved Laccase
(A and B) Details of the mutations in the ChU-B
variant (B) compared with the corresponding
residues in the parental type (A). The F396I and
F454E mutations are shown in yellow, and the
I452V mutation (reverted in ChU-B) in black. Blue
spheres represent copper atoms. The residues of
the internal transfer pathway from T1 Cu to T2/T3
cluster are colored magenta. Residues involved
in the first coordination sphere of the catalytic
coppers and their interactions (as green dashes)
are also represented. The electrostatic surface of
the protein structure is shown in the background.
The 3D structure model is based on the crystal
structure of the Trametes trogii laccase (97%
identity, PDB: 2HRG) (Matera et al., 2008).
See also Figure S2 and Table S4.
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region on halide/OH inhibition (Figure S2; Table S4).
F396I was discovered in the first generation, and it provoked
the greatest improvement in activity of the entire evolutionary
process (157-fold increase in activity over the parental type).
Additional saturation mutagenesis at this position did not con-
fer any further improvement (Figure 1). The highly conserved
Phe396 plays a key role in the redox potential of the T1 site,
and hence in HRPL catalysis (Matera et al., 2008). Phe396 acts
as a bridge connecting the T1 Cu and T2/T3 Cu cluster via
Pro395 (contiguous to the coordinating His394 of the T1 Cu)
and His397, which coordinates the T2 Cu (Figure 4). The F454E
mutation was generated by subjecting position 454 to satura-
tion mutagenesis and subsequent screening, as some mutants
discovered in the first and third generations already contained
a mutation at this position (Figures 1 and S3). We selected six
different mutants with F454P/T/A/G/R/E substitutions, which
boosted activity in blood-buffer up to 2.5-fold (Supplemental
Results). The F454E mutation is contiguous to the coordinating
His455 of the T1 Cu. Analysis of our model revealed that upon
mutation, an H-bond with the imidazole group of His455 appears228 Chemistry & Biology 20, 223–231, February 21, 2013 ª2013 Elsevier Ltd All rights reservto be established (Figure 4). It is generally
accepted that electron transfer from the
substrate to the T1 Cu is the rate-limiting
step of laccase catalysis (Alcalde, 2007;
Gianfreda et al., 1999). Modification of
the second coordination sphere of the
T1 Cu reduces activity at acidic pH values
and simultaneously compensates for T2
Cu inhibition so that ChU-B maintains
activity in the presence of halides and
OH. These results are consistent with
previous studies of an ascomycete low-
redox potential laccase subjected to
comprehensive site-directed mutagen-
esis at the T1 region (Xu et al., 1998).
Recently, the parental type of the current
research—the HRPL OB-1 mutant
evolved for secretion and stability in yeast
(Mate´ et al., 2010)—was analyzed by
a computational algorithm to understandthe physical forces that rule the stability of the variant (Christen-
sen andKepp, 2012). Indeed, the combination of in silico compu-
tational methods (based on Monte Carlo simulations and molec-
ular dynamics) may provide a new twist in the study of this blood
tolerant laccase. In particular, the use of quantum mechanics/
molecular mechanics (QM/MM) methods—for mapping internal
electron transfer pathways (Guallar and Wallrapp, 2008)—as
well as the protein energy landscape exploration (PELE)—for as-
sessing the traffic of halides and hydroxides through the laccase
structure (Borrelli et al., 2005)—could be valuable approaches to
discern the hidden physicochemical principles behind the lac-
case improvements.
SIGNIFICANCE
HRPLs are considered by many as the green biocatalysts of
the 21st century: they easily oxidize hundreds of compounds
using oxygen from air and release water as the only byprod-
uct (Mate´ et al., 2011). Moreover, they can be immobilized
onto electrodes and they mediate direct electron transfer,
permitting their integration into nanobioelectronic devices.ed
Chemistry & Biology
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thereby enabling its incorporation into physiological fluids.
We are currently designing a full wireless 3D-nanobiodevice
prototype for use in human blood, containing an ad hoc
transmitter and a biosensor powered by a biofuel cell, to
which ChU-B is attached (S. S., M.A. A.D.L., R.L., M.P.,
M.F., D.M., D.G.P., W., Schuhmann, L. Gorton, D. Leech,
P. Bartlett, M. Duarte, E. Magner, F. Sebelius, and D. Suther-
land, unpublished data). This technology should permit less
invasive and more reliable real-time in situ monitoring.
Indeed, nanobiodevices can minimize the often-critical
time to detect a potentially life threatening physiological
imbalance and shorten the intervention time for medical
teams. With an extraordinary resistance to halides and
significant activity at neutral/alkaline pH values, the benefits
of our evolved HRPL may also be extended to applications
such as the development of medical bioassays, bioremedia-
tion (e.g., oxidation of pesticides, PAHs, contained-waste
waters, dye processing), pulp-kraft biobleaching, organic
syntheses, and cofactor/coenzyme regeneration, among
other processes in which high pH and/or strong salt con-
tents represent major hurdles (Alcalde et al., 2006; Rodrı´-
guez Couto and Toca Herrera, 2006; Kunamneni et al.,
2008; Riva, 2006; Witayakran and Ragauskas, 2009).
EXPERIMENTAL PROCEDURES
All chemical reagents were of the highest purity commercially available. The
oligonucleotides used along the evolutionary process (Table S5) were
purchased from Isogen Life Science (De Meern, The Netherlands). Culture
media were prepared as described previously (Mate´ et al., 2010).
Laboratory Evolution
For each generation, PCR fragments were cleaned, concentrated and loaded
onto a low melting point preparative agarose gel (Bio-Rad, Hercules, CA), and
then purified using the Zymoclean gel DNA recovery kit (Zymo Research,
Orange, CA). PCR products were cloned under the control of GAL1 promoter
of the pJRoC30 expression shuttle vector (kindly donated by Prof. F.H. Arnold
from Caltech, CA), replacing the parent gene in pJRoC30. To remove the
parent gene, the pJRoC30 plasmid was linearized with BamHI and XhoI
(New England BioLabs, Hertfordshire, UK), and the linear plasmid was
concentrated and purified as described above for the PCR fragments.
First Generation: IvAM
Using the OB-1 mutant as the parental type (Mate´ et al., 2010), a library of over
3,000 clones was constructed by in vivo assembly of mutant libraries with
different mutational spectra (IvAM) (Zuma´rraga et al., 2008). Independent
mutagenic PCR reactions with Taq/MnCl2 (Sigma-Aldrich, Madrid, Spain)
and Mutazyme II DNA polymerase (Genemorph II Random mutagenesis kit,
Stratagene, CA) were carried out on a gradient thermocycler (Mycycler, Bio-
Rad) using the following parameters: 95C for 2 min (1 cycle); 94C for
0.75 min, 53C for 0.75 min, 74C for 3 min (28 cycles); 74C for 10 min
(1 cycle). In a final volume of 50 ml, the Taq/MnCl2 PCR amplification contained
90 nM RMLN, 90 nM RMLC, 0.1 ng/ml template, 0.3 mM dNTPs (0.075 mM
each), 3% DMSO, 1.5 mM MgCl2, 0.01 mM MnCl2, and 0.05 U/ml Taq poly-
merase. Mutazyme II amplification was carried out with 372 nM RMLN,
372 nM RMLC, 40 ng/ml template, 0.8 mM dNTPs (0.2 mM each), 3%
DMSO, and 0.05 U/ml Mutazyme II per 50 ml of reaction product. Under these
conditions the mutational rates of Taq/MnCl2 and Mutazyme II libraries were
0–3 and 4.5–9 mutations per 1,000 bp, respectively. To promote in vivo liga-
tion, overhangs of 40 and 66 bp homologous to the linear vector were de-
signed. The two libraries were mixed in equimolar amounts and transformed
into competent S. cerevisiae cells of the protease-deficient strain BJ5465
(LGC Promochem, Barcelona, Spain) using the yeast transformation kit
(Sigma-Aldrich) together with the linearized vector (ratio vector/library 1:4).Chemistry & Biology 20, 223Transformed cells were plated in synthetic complete drop-out plates and
incubated for 3 days at 30C. Colonies were then picked and subjected to
the screening assay and to three successive rescreenings, as described
below.
Second Generation: Error Prone PCR + IvAM
Using the 35H10 mutant from the first generation as the parental type,
three mutant libraries (700 clones each) were constructed and inde-
pendently screened. The first library was prepared with Taq/MnCl2, the
second with Mutazyme II and the third with IvAM, as described for the first
generation.
Third Generation: Mutagenic StEP and In Vivo DNA Shuffling
Two independent libraries were created and explored using the two best
mutants from the second round, 2E3 and 20F1, as the parental types. For
the first library, the parental types were independently prepared with to Taq/
MnCl2 and themutagenic products in vivo shuffled inS. cerevisiae. The second
library was prepared by in vitro recombination through staggered extension
process (StEP) (Zhao et al., 1998). The StEP-PCR reaction (50 ml final volume)
contained 0.5 mM RMLN, 0.5 mM RMLC, 0.1 ng/ml of each DNA-template,
0.8 mM dNTPs (0.2 mM each), 3% DMSO, 1 mM MgCl2, 0.01 mM MnCl2,
and 0.02 U/ml iProof high-fidelity DNA polymerase (Bio-Rad). The PCR condi-
tions were as follows: 95C for 2 min (1 cycle); 94C for 0.5 min, 55C for
0.33 min (90 cycles). An electrophoretic band of2 kb was purified and further
subjected to mutagenic PCR with Mutazyme II. This mutagenic product was
in vivo shuffled as described above.
Fourth Generation: Site-Directed and Saturation Mutagenesis
Studies
Two individual mutants and three saturation mutagenesis libraries were con-
structed by in vivo overlap extension (IVOE) (Alcalde, 2010) using the 27C7
mutant as the parental template. The PCR reactions were carried out using
the iProof high-fidelity DNA polymerase.
D205NMutant. (Madzak et al., 2006) The primers for PCR 1were RMLN and
D205N-REV and for PCR 2 were D205N-FOR and RMLC.
N426D Mutant. The primers for PCR 1 were RMLN and N426D-REV and for
PCR 2 were N426-FOR and RMLC.
Saturation Mutagenesis at Position 389. The primers for PCR 1 were
RMLN and SAT389-REV and for PCR 2 were SAT389-FOR and RMLC.
Saturation Mutagenesis at Position 396. The primers for PCR 1 were
RMLN and SAT396-REV and for PCR 2 were SAT396-FOR and RMLC.
Saturation Mutagenesis at Position 454. The primers for PCR 1 were
RMLN and SAT454-REV and for PCR 2 were SAT454-FOR and RMLC.
Screening Assay and High-Throughput Protocol
Laccasemutant libraries were screened in a medium (blood-buffer) containing
the colorimetric laccase substrate ABTS and that simulates the composition of
human blood, although it lacks coagulating agents and cells. Blood-buffer
composition: 150 mM NaCl, 18 mM NaHCO3, 1 mg/ml D-(+)-glucose,
4.3 mM urea, 0.87 mM MgSO4, 0.4 mM D-(+)-fructose, 0.1 mM L-cysteine,
and 4.29 mM ABTS in 100 mM sodium phosphate buffer. The blood-buffer
pH was set at 6.5 for the first generation and was gradually increased
throughout evolution to reach physiological pH (7.4) in generation 4. The
general HTP-screening protocol was as reported previously (Mate´ et al.,
2010) with some modifications. Individual clones were picked and cultured
in 96-well plates (Greiner Bio-One, Frickenhausen, Germany) containing
50 ml of minimal medium per well. In each plate, column number 6 was inocu-
lated with the parental type and one well (H1-control) was left uninoculated.
Plates were sealed to prevent evaporation and incubated at 30C and 80%
relative humidity on a shaker at 225 rpm (Minitron-INFORS, Biogen, Spain).
After 48 hr, 160 ml of expressionmediumwas added to eachwell and the plates
were incubated for 24 hr. The plates (master plates) were then centrifuged
(Eppendorf 5810R centrifuge, Germany) for 5 min at 3,000 3 g at 4C and
60 ml of the supernatant was transferred from the master plate onto a replica
plate with the help of a robot (Liquid Handler Quadra 96-320, Tomtec,
Hamden, CT). The replica plate was filled with 140 ml of blood-buffer, and after
briefly stirring the plates and allowing substrate oxidation in blood-buffer,
absorption was measured at 418 nm (εABTS,+ = 36,000 M
1 cm1) in a plate
reader (SpectraMax Plus384, Molecular Devices, Sunnyvale, CA). The plates
were incubated at room temperature until a green color developed and the
absorption was measured again. Relative activities were calculated as the–231, February 21, 2013 ª2013 Elsevier Ltd All rights reserved 229
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against the parental type used as reference in the corresponding plate (the
reference parental types were as follows: 1G, OB-1; 2G, 35H10; 3G, 2E3;
4G, 27C7). To rule out false positives, two consecutive rescreenings were
carried out according to our previously described protocol (Mate´ et al.,
2010), but using the blood-buffer assay described above. A third rescreening
was introduced to obtain a breakdown of the improvements detected in terms
of pH activity profile, Cl tolerance, and thermostability.
Laccase Production and Purification
Laccase variants were produced in S. cerevisiae (with secretion levels of
8 mg/l) and purified to homogeneity as described previously (Mate´ et al.,
2010). For spectroelectrochemical studies, mutants were overproduced in
Pichia pastoris after cloning them into the pPICZaA vector under the control
of the methanol-inducible AOX1 promoter (Pichia expression kit, Life Technol-
ogies, Carlsbad, CA). Secretions levels of 43 mg/l were achieved in a 20L
autoclavable stainless steel bioreactor (Applikon Biotechnology, Schiedam,
The Netherlands).
Measurement of Laccase Activity in Human Plasma and Blood
Human blood was collected in BD Vacutainer blood collection tubes (Plymoth,
UK). Blood samples were centrifuged for 10 min at 3,000 rpm to obtain human
plasma, discarding the pellet after having carefully extracted the supernatant.
Both plasma and blood were supplemented with 10 mM ascorbic acid as
substrate and the pH adjusted to 7.4. The activity of the ChU-B mutant in
both physiological fluids was determined by measuring oxygen consumption
in solution with a Clark electrode. These experiments were performed using
the Oxygraph system (Hansatech Instruments, King’s Lynn, UK), taking into
account the stoichiometry of the reaction: one molecule of O2 is reduced by
oxidizing four substrate molecules. The activity of the ChU-B mutant was
further measured in blood-buffer using the same protocol described above
and the following substrates: potassium ferrocyanide, K4[Fe(CN)6] (5 mM final
concentration); ABTS (5 mM final concentration); and ascorbic acid (10 mM
final concentration). Human plasma and blood manipulation was officially
authorized by the Faculty of Health and Society of the Malmo¨ University.
Biochemical Characterization
Determination of Maximum Turnover Rates in Blood-Buffer
The initial turnover rates were determined in blood-buffer (pH 7.4) for ABTS and
DMP. A typical reaction started upon the addition of the enzyme (4.7 and
22.7 nM for ABTS and DMP, respectively) to the assay mixture (1.3 mM ABTS
or 2.8mMDMP in blood-buffer). All measurementswere performed in triplicate.
pH-Activity Profiles
The pH profiles were determined over a range of pH 2.0–9.0 as described
previously (Camarero et al., 2012).
Halide Inhibition
The inhibitory effect of fluoride, chloride and bromide wasmeasured using two
laccase substrates (ABTS and DMP) at their corresponding optimal pH activity
values (in 100 mM sodium acetate buffer (pH 4.0) for ABTS and 100 mM
sodium tartrate buffer (pH 5.0) for DMP), as well as at physiological pH (in
100 mM sodium phosphate buffer, pH 7.4). Inhibition was determined by the
I50 value (the halide concentration at which only 50% of the initial laccase
activity is retained), as the complexity of the plots complicated the extraction
of the inhibition constant (Ki). The assay mixture contained 2.4 mM ABTS or
DMP, halide (concentrations ranging from 0 to 1100 mM) and purified laccase
(0.2 and 1.7 nM for ABTS and DMP, respectively). Each data point represents
the mean value determined in at least three independent experiments.
Thermostability
The thermostability of the different laccase samples was estimated by deter-
mining their T50 values as reported in a previouswork (Garcı´a-Ruiz et al., 2010).
Spectro-Electrochemical Studies
Determination of Laccase Redox Potential
The redox titration of yellow laccase mutants was carried out as described
previously for the OB-1 parental type (Mate et al., 2012) with some modifica-
tions. Briefly, a microspectroelectrochemical cell containing a gold capillary
electrode was used, with the potential controlled by a three-electrode BAS
LC-3E potentiostat (Bioanalytical Systems, West Lafayette, IN) where a230 Chemistry & Biology 20, 223–231, February 21, 2013 ª2013 ElseAgrAgClrKCl electrode was used as reference electrode (BAS) and a platinum
wire as counter electrode. The absorbance spectra were monitored on
a HR4000 high resolution spectrometer with an effective range of 200–
1,100 nm using a DH-2000 light source, both from Ocean Optics (Dunedin,
FL). The redox potential of the T1 site of the enzyme was determined by
mediated redox titration (MRT) using the spectroelectrochemical set-up
described above. A complex mediator system was used for the MRT contain-
ing three different redox mediators: K4[Fe(CN)6] and K4[Mo(CN)8] with formal
redox potentials of +430 mV and +780 mV versus NHE, respectively, and
K4[W(CN)8] with a formal redox potential of +520 mV versus NHE, synthesized
as described previously (Leipoldt et al., 1974). All experiments were performed
in 50 mM sodium phosphate buffer pH 7.4.
Electrochemical Measurements
Electrochemical experiments were performed with an Autolab PGSTAT30
analyzer controlled by GPES 4.9 software (Eco Chemie, The Netherlands).
Experiments were run in a 3-electrode glass cell using a BAS AgrAgClrKCl
reference electrode (+210 mV versus NHE) and a platinum wire counter elec-
trode. The low-density graphite (LDG electrodes) were abraded with sand-
paper and sonicated. A 5 ml drop of laccase (13 mg/ml) was deposited on
a clean LDG electrode and after it had been absorbed for 20min, the electrode
was set into the electrochemical cell, which was bubbled with O2 (g) at 1 atm
pressure for 15 min. For electrocatalytic measurements, current densities are
expressed relative to the geometric area of the electrodes and potentials are
described relative to that of the NHE. Cyclic voltammograms were recorded
from +1,100 mV to +210 mV versus NHE using a 10-mV/s scan rate.
Protein Modeling
Protein models of the parental and evolved laccases were generated and
analyzed as described previously (Mate´ et al., 2010).
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